Centene stock is expected to report earnings on Jul. 26. The stock is now trading right around the 87.44 buy point from a first-stage double bottom that it cleared earlier. The managed care stock has 95 Relative Strength Rating.
Understand that buying close to when a stock reports can be risky. You don't know how the stock will report and how the market will react, and you don't have enough time to build a profit cushion. You can minimize your exposure by waiting to see the actual numbers and the market's reaction. You can also use an options strategy to limit your potential downside.
Looking For The Best Stocks To Buy And Watch? Start Here
While the company's bottom line growth declined in the company's most recent performance report from 120% to 12%, sales rose 24%, up from 15% in the prior report.
Analysts expect EPS growth of 28% for the quarter, and 9% growth for the full year.
Centene stock has a 98 Composite Rating and holds the No. 2 rank among its peers in the Medical-Managed Care industry group. Humana is the top-ranked stock within the group.
Note: Dates for earnings reports are subject to change. Check the company's website for any updates.